Balance Sheet Henan Lingrui Pharmaceutical Co., Ltd.

Equities

600285

CNE000001501

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2024-09-06			5-day change	1st Jan Change
22.88 ^CNY	-2.72%		-2.05%	+33.72%

08-12	Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
05-13	Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug	MT

4054846de0acc03eeb388bd4d7b1cd.neL_qCMnIUsydJ1z1_DkEPM2j8ePdkDvDr41wvIZ07s.06vS_BEfFwVdAuc3jb2zW7pb-4rXAyKoXPJ0iZl058_Mm6f7VBZxfXwr3A

Published financial data: HENAN LINGRUI PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	2.15B	2.33B	2.69B	3B	3.31B
Other Revenues, Total	3.35M	3.44M	3.48M	3.44M	3.98M
Total Revenues	2.16B	2.33B	2.69B	3B	3.31B
Cost of Goods Sold, Total	498M	544M	708M	838M	889M
Gross Profit	1.66B	1.79B	1.99B	2.16B	2.42B
Selling General & Admin Expenses, Total	1.22B	1.34B	1.48B	1.61B	1.67B
Provision for Bad Debts	1.33M	-4.15M	2.07M	1.99M	4.64M
R&D Expenses	78.67M	97.76M	86.21M	125M	110M
Other Operating Expenses	33.45M	28.4M	37.4M	40.54M	44.84M
Other Operating Expenses, Total	1.33B	1.46B	1.61B	1.78B	1.83B
Operating Income	329M	324M	376M	389M	589M
Interest Expense, Total	-9.96M	-1.1M	-1.9M	-1.14M	-198K
Interest And Investment Income	12.36M	57.89M	43.03M	86.61M	55.87M
Net Interest Expenses	2.4M	56.79M	41.13M	85.47M	55.67M
Currency Exchange Gains (Loss)	-286	782	-1.38K	128	-8.3K
Other Non Operating Income (Expenses)	-291K	-288K	-1.7M	-4.67M	-1.69M
EBT, Excl. Unusual Items	331M	380M	416M	470M	643M
Impairment of Goodwill	-	-500K	-	-	-
Gain (Loss) On Sale Of Investments	-9.99M	-52.06K	45.88K	5.93M	121K
Gain (Loss) On Sale Of Assets	-231K	-2.95M	-20.32M	-102K	-633K
Asset Writedown	-173K	-27.8M	-	-	-1.83M
Other Unusual Items	20.89M	15.4M	17.74M	41.34M	12.49M
EBT, Incl. Unusual Items	341M	364M	413M	517M	653M
Income Tax Expense	48.14M	39.82M	50.85M	51.7M	84.93M
Earnings From Continuing Operations	293M	324M	362M	465M	568M
Net Income to Company	293M	324M	362M	465M	568M
Minority Interest	1.29M	1.11M	-957K	-370	-6.4K
Net Income - (IS)	294M	325M	362M	465M	568M
Net Income to Common Incl Extra Items	294M	325M	362M	465M	568M
Net Income to Common Excl. Extra Items	294M	325M	362M	465M	568M
Per Share Items
Net EPS - Basic	0.51	0.57	0.65	0.84	1.01
Basic EPS - Continuing Operations	0.51	0.57	0.65	0.84	1.01
Basic Weighted Average Shares Outstanding	575M	568M	556M	557M	561M
Net EPS - Diluted	0.51	0.57	0.64	0.82	1
Diluted EPS - Continuing Operations	0.51	0.57	0.64	0.82	1
Diluted Weighted Average Shares Outstanding	575M	568M	567M	568M	566M
Normalized Basic EPS	0.36	0.42	0.47	0.53	0.72
Normalized Diluted EPS	0.36	0.42	0.46	0.52	0.71
Dividend Per Share	0.3	0.4	0.5	0.6	0.8
Payout Ratio	33.39	55.03	61.91	62.07	60.6
Supplemental Items
EBITDA	396M	392M	448M	463M	665M
EBITA	339M	334M	387M	400M	599M
EBIT	329M	324M	376M	389M	589M
EBITDAR	401M	397M	453M	468M	669M
Total Revenues (As Reported)	2.16B	2.33B	2.69B	3B	3.31B
Effective Tax Rate - (Ratio)	14.11	10.93	12.3	10	13
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	52.38M	58.89M	67.37M	85.29M	108M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-4.24M	-19.07M	-16.51M	-33.58M	-23.09M
Normalized Net Income	208M	239M	259M	294M	402M
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	363K	234K
Non-Cash Pension Expense	-	135K	695K	-	-
Supplemental Operating Expense Items
Advertising Expense	219M	357M	438M	-	265M
Selling and Marketing Expenses	1.1B	1.18B	1.3B	1.44B	1.5B
General and Administrative Expenses	115M	156M	183M	164M	171M
Research And Development Expense From Footnotes	78.67M	97.76M	86.21M	125M	110M
Net Rental Expense, Total	4.92M	4.92M	5.31M	4.88M	4.65M
Imputed Operating Lease Interest Expense	1.41M	195K	360K	202K	40.1K
Imputed Operating Lease Depreciation	3.52M	4.73M	4.95M	4.68M	4.61M
Maintenance & Repair Expenses, Total	3.41M	5.55M	6.2M	5.24M	3.1M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	1.75M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	12.32M
Stock-Based Comp., Other (Total)	-	-	28.6M	37.62M	-
Total Stock-Based Compensation	-	-	28.6M	37.62M	14.07M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	741M	732M	801M	1.18B	1.5B
Short Term Investments	-	40.08M	141M	125M	95.63M
Trading Asset Securities, Total	27.83M	57.23M	280M	150M	206K
Total Cash And Short Term Investments	769M	830M	1.22B	1.46B	1.59B
Accounts Receivable, Total	644M	709M	431M	512M	499M
Other Receivables	18.69M	8.54M	9.58M	21.37M	19.35M
Total Receivables	663M	717M	441M	533M	518M
Inventory	287M	331M	428M	486M	467M
Prepaid Expenses	-	380K	8.51K	-	-
Other Current Assets, Total	35.69M	37.98M	39.87M	33.58M	18.51M
Total Current Assets	1.75B	1.92B	2.13B	2.51B	2.6B
Gross Property Plant And Equipment	1.08B	1.09B	1.15B	1.19B	1.19B
Accumulated Depreciation	-312M	-362M	-421M	-484M	-541M
Net Property Plant And Equipment	766M	730M	733M	707M	648M
Long-term Investments	334M	350M	365M	349M	1.07B
Goodwill	500K	-	-	-	-
Other Intangibles, Total	242M	235M	237M	204M	203M
Deferred Tax Assets Long-Term	78.41M	97.79M	116M	159M	187M
Deferred Charges Long-Term	98.05M	87.15M	65.53M	51.54M	36.73M
Other Long-Term Assets, Total	42.48M	41.45M	145M	367M	29.98M
Total Assets	3.32B	3.46B	3.79B	4.34B	4.77B
Liabilities
Accounts Payable, Total	67.66M	78.81M	78.01M	68.02M	57.38M
Accrued Expenses, Total	416M	528M	600M	918M	1.11B
Short-term Borrowings	281M	166M	272M	151M	200M
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	-	-	1.65M	1.22M	1.08M
Current Income Taxes Payable	47.18M	52.46M	46.9M	55.54M	70.72M
Unearned Revenue Current, Total	-	71.73M	79.09M	154M	114M
Other Current Liabilities	202M	169M	359M	364M	347M
Total Current Liabilities	1.01B	1.07B	1.44B	1.71B	1.9B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	7.9M	6.2M	6.96M
Unearned Revenue Non Current	55.04M	48.26M	42.78M	38.55M	39.78M
Deferred Tax Liability Non Current	26.5M	21.09M	18.18M	29.22M	26.32M
Total Liabilities	1.1B	1.14B	1.51B	1.79B	1.97B
Common Stock, Total	568M	568M	568M	567M	567M
Additional Paid In Capital	340M	306M	272M	310M	326M
Retained Earnings	1.19B	1.34B	1.48B	1.66B	1.89B
Treasury Stock	-	-	-98.19M	-67.62M	-47.4M
Comprehensive Income and Other	117M	98.31M	56.08M	76.74M	51M
Total Common Equity	2.21B	2.31B	2.28B	2.55B	2.79B
Minority Interest	10.56M	9.43M	7.59M	7.55M	7.66M
Total Equity	2.22B	2.32B	2.29B	2.56B	2.8B
Total Liabilities And Equity	3.32B	3.46B	3.79B	4.34B	4.77B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	568M	562M	565M	570M	564M
ECS Total Common Shares Outstanding	568M	568M	565M	570M	564M
Book Value / Share	3.89	4.07	4.04	4.48	4.95
Tangible Book Value	1.97B	2.08B	2.04B	2.35B	2.59B
Tangible Book Value Per Share	3.46	3.66	3.62	4.12	4.59
Total Debt	281M	166M	282M	159M	208M
Net Debt	-488M	-664M	-940M	-1.3B	-1.39B
Debt Equivalent Oper. Leases	39.38M	39.38M	42.47M	39.05M	37.2M
Minority Interest, Total (Incl. Fin. Div)	10.56M	9.43M	7.59M	7.55M	7.66M
Equity Method Investments, Total	105M	98.58M	117M	71.65M	71.27M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	143M	185M	193M	218M	192M
Inventories - Work In Process, Total	56.75M	61.65M	117M	171M	172M
Inventories - Finished Goods, Total	87.33M	85.13M	128M	106M	109M
Buildings, Total	577M	578M	583M	595M	594M
Machinery, Total	492M	512M	535M	582M	582M
Full Time Employees	2.62K	2.6K	2.5K	2.52K	2.53K
Accumulated Allowance for Doubtful Accounts (Supple)	11.76M	11.11M	12.69M	14.42M	18.93M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	294M	325M	362M	465M	568M
Depreciation & Amortization - CF	57.37M	58.13M	61.77M	65.12M	67.74M
Amortization of Goodwill and Intangible Assets - (CF)	10.2M	10.33M	11.03M	11.13M	9.88M
Depreciation & Amortization, Total	67.57M	68.46M	72.8M	76.25M	77.62M
Amortization of Deferred Charges, Total - (CF)	2.33M	4.86M	3.92M	2.81M	4.89M
(Gain) Loss From Sale Of Asset	231K	-79.48K	-34.62K	-24.59K	-47.65K
(Gain) Loss on Sale of Investments - (CF)	9.99M	-41.16M	-30.6M	-64.58M	-20.28M
Asset Writedown & Restructuring Costs	350K	30.83M	20.36M	127K	2.52M
Provision and Write-off of Bad Debts	1.33M	-4.15M	2.07M	1.99M	4.64M
Other Operating Activities, Total	13.11M	5.4M	12.17M	5.82M	3.83M
Change In Accounts Receivable	-109M	-70.53M	236M	-76.41M	-43.44M
Change In Inventories	36.79M	-44.51M	-106M	-58.19M	26.9M
Change In Accounts Payable	137M	195M	261M	478M	198M
Change In Deferred Taxes	-4.24M	-19.07M	-16.51M	-33.58M	-23.09M
Change in Other Net Operating Assets	-	-	28.6M	37.62M	14.07M
Cash from Operations	450M	451M	846M	835M	813M
Capital Expenditure	-59.04M	-71.82M	-76.91M	-26.99M	-21.2M
Sale of Property, Plant, and Equipment	841K	204K	474K	12.23M	10.15M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-158M	75.67M	-483M	-83.02M	-232M
Other Investing Activities, Total	4.13M	7.82M	13.63M	13.97M	13.3M
Cash from Investing	-212M	11.87M	-546M	-83.81M	-230M
Short Term Debt Issued, Total	330M	172M	236M	90M	103M
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	330M	172M	236M	90M	103M
Short Term Debt Repaid, Total	-396M	-287M	-130M	-170M	-20M
Long-Term Debt Repaid, Total	-	-	-1.68M	-2.28M	-1.89M
Total Debt Repaid	-396M	-287M	-132M	-172M	-21.89M
Issuance of Common Stock	-	-	75.91M	-	-
Repurchase of Common Stock	-	-	-184M	-1.85M	-787K
Common Dividends Paid	-98.31M	-179M	-224M	-289M	-344M
Common & Preferred Stock Dividends Paid	-98.31M	-179M	-224M	-289M	-344M
Other Financing Activities, Total	-114M	-12.09M	-3.09M	-120K	-8.62M
Cash from Financing	-278M	-306M	-231M	-373M	-273M
Foreign Exchange Rate Adjustments	14.72K	-95.19K	-26.69K	35.99K	-2.37K
Net Change in Cash	-39.72M	156M	68.93M	378M	311M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	308M	315M	357M	395M	477M
Levered Free Cash Flow	237M	269M	704M	584M	632M
Unlevered Free Cash Flow	244M	270M	705M	584M	632M
Change In Net Working Capital	-27.37M	-65.88M	-441M	-252M	-189M
Net Debt Issued / Repaid	-65.5M	-115M	105M	-82.28M	80.96M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	6.39	5.97	6.49	5.98	8.07
Return on Total Capital	8.43	8.11	9.31	9.2	12.86
Return On Equity %	13.59	14.28	15.73	19.21	21.21
Return on Common Equity	13.72	14.39	15.75	19.27	21.27
Margin Analysis
Gross Profit Margin %	76.92	76.67	73.72	72.1	73.17
SG&A Margin	56.43	57.56	55.07	53.56	50.58
EBITDA Margin %	18.37	16.82	16.62	15.44	20.07
EBITA Margin %	15.71	14.32	14.39	13.33	18.08
EBIT Margin %